41 – 50 of 174
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2013
-
Mark
Continuous DOPA synthesis from a single AAV: dosing and efficacy in models of Parkinson's disease.
(
- Contribution to journal › Article
-
Mark
Characterization of cognitive deficits in rats overexpressing human alpha-synuclein in the ventral tegmental area and medial septum using recombinant adeno-associated viral vectors.
(
- Contribution to journal › Article
-
Mark
LAMP2A as a therapeutic target in Parkinson disease
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Hypothalamic expression of mutant huntingtin contributes to the development of depressive-like behavior in the BAC transgenic mouse model of Huntingtons disease
(
- Contribution to journal › Article
-
Mark
The behavioural and neuropathological impact of intranigral AAV-alpha-synuclein is exacerbated by systemic infusion of the Parkinson's disease-associated pesticide, rotenone, in rats
(
- Contribution to journal › Article
-
Mark
Trophic factors differentiate dopamine neurons vulnerable to Parkinson's disease
(
- Contribution to journal › Article
-
Mark
Variability in Neuronal Expression of Dopamine Receptors and Transporters in the Substantia Nigra
(
- Contribution to journal › Article
-
Mark
Boosting chaperone-mediated autophagy in vivo mitigates alpha-synuclein-induced neurodegeneration
(
- Contribution to journal › Article
-
Mark
Animal Models of Parkinson's Disease: Limits and Relevance to Neuroprotection Studies
(
- Contribution to journal › Scientific review
-
Mark
Transduced Wild-Type but Not P301S Mutated Human Tau Shows Hyperphosphorylation in Transgenic Mice Overexpressing A30P Mutated Human Alpha-Synuclein
(
- Contribution to journal › Article